Inflammation Cream in pharma franchise in Tamil Nadu

Inflammation Cream in PCD pharma franchise in Panaji

Inflammation Cream in top pharma company in Sangli

Inflammation Cream in pcd pharma supplier in Jalna

Inflammation Cream in phama franchise company in India
Inflammation Cream in phama distributor in Firozabad

Home/Products /clobetasol-0-point-05-w-w-miconazole-2-w-w-neomycin-0-point-5-w-w-cream

Diziderm NM Cream

Composition : Clobetasol (0.05% w/w) + Miconazole (2% w/w) + Neomycin (0.5% w/w)

Dosage Form : Cream

Packaging Type : Tube

Packaging : 15gm

Price : ₹89/-

        Tranderm NM Cream is a powerful combination topical treatment that combines Clobetasol (0.05% w/w), Miconazole (2% w/w), and Neomycin (0.5% w/w). This cream is designed to treat various skin conditions, particularly those caused by fungal, bacterial, or inflammatory components. Its triple action formulation targets multiple skin issues by combining an anti-inflammatory corticosteroid, an antifungal agent, and an antibacterial antibiotic.

  • Clobetasol (0.05%): A potent corticosteroid known for its anti-inflammatory properties, Clobetasol helps reduce redness, swelling, and itching associated with conditions like eczema, psoriasis, or dermatitis.
  • Miconazole (2%): An antifungal agent that works by disrupting the growth of fungi, Miconazole is particularly effective against dermatophytes and yeast infections, such as athlete's foot, ringworm, and candidiasis.
  • Neomycin (0.5%): A broad-spectrum antibiotic that fights bacterial infections, Neomycin helps prevent secondary bacterial infections in skin conditions, promoting faster healing and reducing complications.

This cream offers a comprehensive solution for patients dealing with mixed infections or inflammatory skin conditions that also have fungal or bacterial involvement. Its effectiveness in managing both the cause and the symptoms of these conditions makes it a preferred choice in dermatological care.

Read More

About the Product

        Tranderm NM Cream is a powerful combination topical treatment that combines Clobetasol (0.05% w/w), Miconazole (2% w/w), and Neomycin (0.5% w/w). This cream is designed to treat various skin conditions, particularly those caused by fungal, bacterial, or inflammatory components. Its triple action formulation targets multiple skin issues by combining an anti-inflammatory corticosteroid, an antifungal agent, and an antibacterial antibiotic.

  • Clobetasol (0.05%): A potent corticosteroid known for its anti-inflammatory properties, Clobetasol helps reduce redness, swelling, and itching associated with conditions like eczema, psoriasis, or dermatitis.
  • Miconazole (2%): An antifungal agent that works by disrupting the growth of fungi, Miconazole is particularly effective against dermatophytes and yeast infections, such as athlete's foot, ringworm, and candidiasis.
  • Neomycin (0.5%): A broad-spectrum antibiotic that fights bacterial infections, Neomycin helps prevent secondary bacterial infections in skin conditions, promoting faster healing and reducing complications.

This cream offers a comprehensive solution for patients dealing with mixed infections or inflammatory skin conditions that also have fungal or bacterial involvement. Its effectiveness in managing both the cause and the symptoms of these conditions makes it a preferred choice in dermatological care.

Local irritation, redness, or stinging sensation may occur. Prolonged use may lead to skin thinning or systemic side effects. Discontinue if any severe allergic reaction occurs.

Tranderm NM Cream is indicated for the treatment of fungal infections with bacterial superinfection, eczema, psoriasis, dermatitis, and other inflammatory skin conditions with secondary infections.

For external use only. Avoid contact with eyes. If irritation persists or worsens, consult a healthcare professional.

Store in a cool, dry place, away from direct sunlight, and below 25°C. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation